The BGTC is Working To Streamline The Development of Gene Therapies for Rare Diseases
The FDA, the NIH, 5 nonprofits, and 10 pharmaceutical companies, have formed an official partnership to accelerate gene therapy development for rare diseases. Out of 7,000 known rare diseases, just…